Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy

Abstract

Purpose Transrectal ultrasound guided prostate biopsy results rely on physician ability to target the gland according to the biopsy schema. However, to our knowledge it is unknown how accurately the freehand, transrectal ultrasound guided biopsy cores are placed in the prostate and how the geometric distribution of biopsy cores may affect the prostate cancer detection rate. Materials and Methods To determine the geometric distribution of cores, we developed a biopsy simulation system with pelvic mock-ups and an optical tracking system. Mock-ups were biopsied in a freehand manner by 5 urologists and by our transrectal ultrasound robot, which can support and move the transrectal ultrasound probe. We compared 1) targeting errors, 2) the accuracy and precision of repeat biopsies, and 3) the estimated significant prostate cancer (0.5 cm3 or greater) detection rate using a probability based model. Results Urologists biopsied cores in clustered patterns and under sampled a significant portion of the prostate. The robot closely followed the predefined biopsy schema. The mean targeting error of the urologists and the robot was 9.0 and 1.0 mm, respectively. Robotic assistance significantly decreased repeat biopsy errors with improved accuracy and precision. The mean significant prostate cancer detection rate of the urologists and the robot was 36% and 43%, respectively (p <0.0001). Conclusions Systematic biopsy with freehand transrectal ultrasound guidance does not closely follow the sextant schema and may result in suboptimal sampling and cancer detection. Repeat freehand biopsy of the same target is challenging. Robotic assistance with optimized biopsy schemas can potentially improve targeting, precision and accuracy. A clinical trial is needed to confirm the additional benefits of robotic assistance.

Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach

“…However, this leads to misclassification of disease in men at risk of prostate cancer 1 . Under-sampling of the anterior gland and the deployment of the needle blind to the location of the lesion can potentially miss clinically significant disease whilst also failing to directly hit the highest grade disease 1 . Additionally, this pathway can also result in overdiagnosis and overtreatment 2 .…”

MRI-Safe Robot for Endorectal Prostate Biopsy

“…The biopsy procedures are cancer “blind”, aiming to sample the gland systematically in search of possible tumors. Since PCa is a heterogeneous multifocal disease, untargeted biopsies often lead to the detection of small, clinically insignificant tumors and/or miss significant cancers [3, 4]. …”

Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology

“…Prostate cancers of the 1980s were larger and easier to detect by systematic sampling than those diagnosed a few decades later 8 , as PSA screening became prevalent and sizeable lesions were removed from the pool. Moreover, TRUS-guided ‘systematic’ sampling is not always truly systematic, as operator bias using the freehand method often results in sub-optimal spacing within the desired schema 9 . Thus, the ‘blind’ TRUS-guided biopsy has important limitations.…”